Federal Supply Schedule V797D70255
Award Date
9/29/17
Last Date to Order
9/30/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Galderma Laboratories, L.P.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Noven Therapeutics LLC, a for-profit foreign-owned organization. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and has a ceiling value of $31,335,540.00. The period of performance runs from the award date of October 15, 2020 through the ultimate completion date of October 14, 2025.
The contract is intended to procure a range of pharmaceutical and...
The Federal Supply Schedule contract awarded by the U.S. Department of Veterans Affairs (VA) to LEO Pharma Inc. covers the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a period of performance from May 15, 2023 to May 15, 2028 and a total ceiling value of $29,000,000.00.
The contract aims to provide the VA's Veterans Integrated Service Network 12 with a wide range of pharmaceutical and hematology-related products from LEO...
The provided information describes a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 12 to Medexus Pharma Inc. The multiple-award, indefinite-delivery vehicle (IDV) contract has a ceiling value of $12,000,000 and a period of performance through September 2025.
The purpose of this FSS contract is to procure various drugs, pharmaceuticals, and hematology-related products for...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to CMP Pharma Inc., a for-profit manufacturer of pharmaceutical products. The contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, has a ceiling value of $4,500,000.00 and a period of performance through July 14, 2025.
The contractor primarily provides pharmaceutical creams and suspensions, such as TAC/EUCERIN, TRIAMCINOLONE/ABSORBASE, and SPS SUSP, to likely health-related government...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Biofrontera Inc., a for-profit organization. The contract has a ceiling value of $225,000.00 and a period of performance from June 15, 2024, to June 15, 2029.
The contract is for the delivery of Drugs, Pharmaceuticals, & Hematology Related Products (FSC 65 I B) to the VISN 12 agency. While no set-asides were used, the contract was...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to EMD Serono Inc. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and has a ceiling value of $271,515,660.00. The period of performance runs from the award date of April 15, 2018 through April 14, 2025.
The contract is intended to procure a wide range of pharmaceutical and hematology-related products for the Department...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency within the Department of Veterans Affairs. The contract was awarded to Metacel Pharmaceuticals LLC, a for-profit organization, on February 1, 2025 and has a period of performance through January 31, 2030. The contract has a ceiling value of $225,000.00 and is for the provision of "65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED...
The federal contract IDV award is a multiple-award Federal Supply Schedule (FSS) contract with Dermavant Sciences Inc. as the prime contractor. The contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 and has a ceiling value of $5,066,433.25 with a period of performance through January 14, 2028.
The purpose of this FSS contract is to provide drugs, pharmaceuticals, and hematology-related products to the VA. As an FSS contract, it allows...
The Department of Veterans Affairs, a civilian agency, awarded a Federal Supply Schedule contract to Helsinn Therapeutics (U.S.), Inc. to provide the pharmaceutical product VALCHLOR. VALCHLOR is used to treat cutaneous T-cell lymphoma. The contract has a ceiling value of $33,573,490 and a period of performance from March 2025 to February 2030.
In addition to the Federal Supply Schedule contract, the VA has also awarded Helsinn Therapeutics a single-award Blanket Purchase Agreement (BPA) to...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, to Legacy Pharma USA, Inc. The multiple-award contract has a ceiling value of $25,000.00 and a period of performance through September 15, 2023.
The contract provides for the interim delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. As a Federal Supply...